Sermorelin: What the Research Says About the GHRH Analog
Sermorelin is one of the foundational growth-hormone-releasing hormone analogs in research, valued for working with the body's own GH machinery rather than overriding it. This overview explains what Sermorelin is and what the research describes, strictly for educational and research context.
What Sermorelin actually is
Sermorelin is a synthetic analog of growth-hormone-releasing hormone (GHRH) — specifically the first 29 amino acids (GHRH 1-29), the shortest fragment that retains full biological activity. It stimulates the pituitary gland to produce and release growth hormone naturally.
What the research explores
Because Sermorelin works through the GHRH pathway, research has examined its effects on natural, pulsatile GH release rather than direct GH administration. It is frequently studied alongside other GHRH analogs such as Tesamorelin and the longer-acting CJC-1295, which sit in the same family.
Handling and preparation
Sermorelin is supplied as a lyophilised powder, kept cold and protected from light, then reconstituted for laboratory work. Our reconstitution guide and the on-site peptide calculator walk through preparing a solution and calculating concentration. Every batch ships with a per-batch Certificate of Analysis.
Important context
This article summarises published research for educational purposes only. Sermorelin is supplied strictly for laboratory and research use only — not for human or veterinary use, consumption, or injection. Nothing here is medical advice, a recommendation, or a dosing protocol.
The bottom line
Sermorelin is a GHRH(1-29) analog studied for stimulating the body's own pulsatile growth-hormone release, within the broader GHRH-analog family. As with everything we carry, our Sermorelin comes with full batch documentation and a verifiable COA.
Research use only. Educational content, not medical advice.